0001000229-18-000059.txt : 20180403 0001000229-18-000059.hdr.sgml : 20180403 20180403172909 ACCESSION NUMBER: 0001000229-18-000059 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180331 FILED AS OF DATE: 20180403 DATE AS OF CHANGE: 20180403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: van Kempen Margaret Ann CENTRAL INDEX KEY: 0001550876 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14273 FILM NUMBER: 18734717 MAIL ADDRESS: STREET 1: ATJEHWEG 16 CITY: NOORDWIJK STATE: P7 ZIP: 2202 AP ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CORE LABORATORIES N V CENTRAL INDEX KEY: 0001000229 STANDARD INDUSTRIAL CLASSIFICATION: OIL, GAS FIELD SERVICES, NBC [1389] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: STRAWINSKYLAAN 913 STREET 2: TOWER A, LEVEL 9 CITY: 1077 XX AMSTERDAM STATE: P7 ZIP: 1077 XX BUSINESS PHONE: 3124203191 MAIL ADDRESS: STREET 1: 6316 WINDFERN CITY: HOUSTON STATE: TX ZIP: 77040 4 1 wf-form4_152279093579691.xml FORM 4 X0306 4 2018-03-31 0 0001000229 CORE LABORATORIES N V CLB 0001550876 van Kempen Margaret Ann ATJEHWEG 16 NOORDWIJK P7 2202 AP NETHERLANDS 1 0 0 0 Common Shares 2018-03-31 4 M 0 1436 0 A 3217 D Common Shares 2018-03-31 4 F 0 747 0 D 2470 D Common Shares 2018-04-01 4 M 0 1299 0 A 3769 D Common Shares 2018-04-01 4 F 0 676 0 D 3093 D Restricted Shares 0.0 2018-04-01 4 A 0 1387 0 A Common Shares 1387.0 1387 D Restricted Shares 0.0 2018-03-31 4 M 0 1436 0 D Common Shares 1436.0 0 D Restricted Shares 0.0 2018-04-01 4 M 0 1299 0 D Common Shares 1299.0 0 D The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period ending April 1, 2019, subject to the terms of issuance. The Restricted Shares vested, without performance criteria, at the end of a three-year vesting period ending April 1, 2018, subject to the terms of issuance. The Restricted Shares vested, without performance criteria, at the end of a one-year vesting period ending April 1, 2018, subject to the terms of issuance. /s/ Mark Elvig, Attorney-in-Fact 2018-03-31